• Cohu, Inc. recently reported that two customers placed follow-on orders totaling US$30,000,000 for its Eclipse platform with active thermal control, supporting testing of next-generation high-performance computing processors and including expected deliveries over the next few quarters.
• One of these customers also adopted Cohu’s PAICe Prescriptive analytics software, introducing a new source of recurring subscription revenue while aiming to boost equipment efficiency at an outsourced semiconductor assembly and test partner.
• We’ll now examine how these Eclipse follow-on orders and the added PAICe Prescriptive subscription shape Cohu’s existing investment narrative.

We've uncovered the 12 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

Cohu Investment Narrative Recap

To own Cohu, I think you have to believe its test and inspection platforms can earn a durable role in complex semiconductor manufacturing, especially in high‑performance computing, while the company works back from recent losses. The US$30,000,000 Eclipse follow‑on orders and new PAICe Prescriptive subscription support the near term high‑performance computing catalyst, but they do not remove key risks around customer concentration and the non‑linear nature of semiconductor demand.

The most relevant prior announcement is the March 17, 2026 Eclipse multi‑unit order from a U.S. semiconductor manufacturer for next‑generation HPC and AI datacenter processors. Together with the new follow‑on orders, it reinforces Eclipse’s role in high‑performance computing, directly tied to Cohu’s effort to win qualifications in advanced test handlers, while still leaving open the risk that competitors could secure future sockets if Cohu’s platforms are not broadly adopted.

But investors should also recognize how concentrated wins in high‑performance computing could leave Cohu exposed if one of these key customers were to...

Cohu's narrative projects $703.9 million revenue and $30.1 million earnings by 2029. This requires 15.8% yearly revenue growth and a $104.4 million earnings increase from -$74.3 million today.

Uncover how Cohu's forecasts yield a $32.67 fair value, in line with its current price.

Exploring Other Perspectives

One Simply Wall St Community member currently pegs Cohu’s fair value at US$32.67, highlighting how a single estimate can differ from prevailing prices. Against this, the reliance on cyclical semiconductor upswings and a few large customers means readers may want to compare that view with how sensitive Cohu’s results could be to any delay in high‑performance computing test demand.

Explore another fair value estimate on Cohu - why the stock might be worth as much as $32.67!

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Cohu research is our analysis highlighting 1 key reward and 1 important warning sign that could impact your investment decision.
• Our free Cohu research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Cohu's overall financial health at a glance.

Ready To Venture Into Other Investment Styles?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• Outshine the giants: these 22 early-stage AI stocks could fund your retirement.
• Find 62 companies with promising cash flow potential yet trading below their fair value.
• Invest in the nuclear renaissance through our list of 93 elite nuclear energy infrastructure plays powering the global AI revolution.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.